Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;77(5):593-598.
doi: 10.1007/s40265-017-0718-0.

Plecanatide: First Global Approval

Zaina T Al-Salama  1 , Yahiya Y Syed  2
Affiliations
Review

Plecanatide: First Global Approval

Zaina T Al-Salama et al. Drugs. 2017 Apr.

Abstract

Plecanatide (TrulanceTM) is an oral guanylate cyclase-C agonist that is being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It is a synthetic analogue of human uroguanylin, a 16 amino acid peptide that regulates ion and fluid transport in the gastrointestinal tract. In January 2017, plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Plecanatide is undergoing phase III investigation in IBS-C. This article summarizes the milestones in the development of plecanatide leading to this first approval in CIC.

PubMed Disclaimer

References

    1. Dig Dis Sci. 2013 Sep;58(9):2580-6 - PubMed
    1. World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):213-22 - PubMed
    1. Am J Gastroenterol. 2017 Apr;112(4):613-621 - PubMed

MeSH terms

LinkOut - more resources